Materias dentro de su búsqueda.
Mostrando 1,561 - 1,580 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.35s Limitar resultados
  1. 1561
    por Toshikuni, Nobuyuki
    Publicado 2017
    “…Chronic hepatitis C virus (HCV) infection may eventually lead to liver cirrhosis (LC), a condition associated with a high risk of liver failure and hepatocellular carcinoma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
  2. 1562
    “…Background and Aims: Recurrent infection of hepatitis C virus (HCV) in liver transplant (LT) recipients is universal and associated with significant morbidity and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C
  3. 1563
    “…BACKGROUND: The prevalence of hepatitis C virus (HCV) in Egypt is quite high, and the combined oral direct-acting antiviral agents (DAAs) may have impressive results. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of Chronic Hepatitis C Virus Treatment by Combination Therapy on Cardiovascular System
  4. 1564
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts – 2016
  5. 1565
    “…BACKGROUND: Hepatitis C is an important public health problem about which there is currently scarce epidemiological information. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C hospitalizations in Spain, 2004-2013: a retrospective epidemiological study
  6. 1566
    “…MC is triggered by hepatitis C virus (HCV) chronic infection in the majority of cases; it represents the prototype of autoimmune-lymphoproliferative disorders complicating a significant proportion of patients with chronic HCV infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia
  7. 1567
    “…The prevalence of hepatitis C virus (HCV) infection amongst patients with chronic kidney disease (CKD) and end-stage renal disease exceeds that of the general population. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease
  8. 1568
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection
  9. 1569
    por Kanda, Tatsuo, Moriyama, Mitsuhiko
    Publicado 2017
    “…Hepatitis C virus (HCV) infection induces steatosis and is accompanied by multiple metabolic alterations including hyperuricemia, reversible hypocholesterolemia and insulin resistance. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
  10. 1570
    “…BACKGROUND: Hepatitis C virus (HCV)-infected patients require a specific continuum of care (CoC) from HCV screening to treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Continuum of hepatitis C care in France: A 20-year cohort study
  11. 1571
    “…Despite having a relatively low prevalence in the Iranian general population, the burden of hepatitis C virus (HCV) infection is on the rise, and hepatitis C is predicted to be the most important leading cause of viral hepatitis-related mortality in the near future in Iran. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lurking epidemic of hepatitis C virus infection in Iran: A call to action
  12. 1572
    “…Background and Aims: Hepatitis C virus (HCV) cirrhosis is the leading indication for liver transplantation in the United States and recurrent HCV following liver transplantation is a major cause of allograft loss and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C
  13. 1573
    “…BACKGROUND: Despite emerging hepatitis C virus (HCV) treatments, barriers remain within the cascade of care (CoC) that limit impact in real-world practice. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of the Hepatitis C Cascade of Care in a Multidisciplinary Infectious Diseases Clinic
  14. 1574
    “…BACKGROUND: Enormous advances in treating/curing patients suffering from Hepatitis C (HepC) infection have occurred; resulting in many states mandating screening for HepC for older individuals. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Is there Failure to Screen for Hepatitis C in Newborns Suffering from Neonatal Abstinence Syndrome?
  15. 1575
    “…OBJECTIVE: The objectives of this study were to estimate the prevalence of Hepatitis C among six Italian Local Health Units (LHUs), to describe patient and antiviral drug characteristics, and to estimate the health care consumption rates and related costs for the management of patients affected by hepatitis C virus (HCV) infection by using data from routine clinical practice. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiology, patient profile, and health care resource use for hepatitis C in Italy
  16. 1576
    “…Although chronic hepatitis C virus (HCV) infection affect 185 million people world-wide, pathomechanism of liver damage is still unclear. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Megamitochondria formation in hepatocytes of patient with chronic hepatitis C – a case report
  17. 1577
    “…Designing services with the capacity and expertise to meet the needs of the chronic hepatitis C (CHC) population in the era of direct acting antivirals (DAAs), and widening access to such treatments, requires detailed understanding of the characteristics and healthcare needs of the existing patient population. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comorbidities and medications of patients with chronic hepatitis C under specialist care in the UK
  18. 1578
    “…AIM: To evaluate the potential value of using a serological assay to quantitate the hepatitis C virus core antigen (HCV-Ag) when monitoring patients with chronic hepatitis C being treated with direct-acting antivirals (DAAs). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods
  19. 1579
    “…CASE PRESENTATION: We report a case of re-infection of hepatitis C in a prisoner treated with a direct-acting antiviral. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Why is there still hepatitis C transmission in Australian prisons? A case report
  20. 1580
    “…The hepatitis C virus (HCV) infection is associated with various extrahepatic manifestations, which are correlated with poor outcomes, and thus increase the morbidity and mortality of chronic hepatitis C (CHC). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Internal driving factors leading to extrahepatic manifestation of the hepatitis C virus infection
Herramientas de búsqueda: RSS